On Nov. 28, the Centers for Medicare & Medicaid Services (CMS) released the final 2026 Home Health Rule, which makes a major change to how continuous glucose monitors (CGMs) and insulin pumps are covered for people with diabetes on Medicare. The American Diabetes Association® (ADA) is deeply concerned that this change could limit access to certain CGMs and insulin pumps and interrupt care that is currently working for patients.
The ADA has spent months educating policymakers and regulators about the importance of prioritizing patient and provider choice for CGMs and insulin pumps. We continue to stress that the type and selection of devices should be individualized based on a person’s specific needs, circumstances, preferences, and skill level, as reflected in the ADA's Standards of Care.
The ADA urges CMS to work closely with the diabetes community to make sure Medicare beneficiaries do not experience gaps in access, coverage, or affordability as these changes roll out. Our priority is ensuring that everyone with diabetes can continue to access the life-saving devices they need.
###
About the American Diabetes Association
The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure diabetes—and we’re not stopping. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we’re fighting for them all. To learn more or to get involved, visit us at or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (@AmDiabetesAssn).
